Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Baume

Showing results (31-40 of 52) with videos related to

Pageof 6
Sort By:
British Journal of Haematology|January 1, 1993
In vivo administration of recombinant granulocyte colony stimulating factor corrects acquired neutrophil function deficiency association with chronic graft-versus-host diseaseA M Stoppa, C Fossat, D Sainty, et al.
Bone Marrow Transplantation|May 1, 1994
Phase I study of in vivo lenograstim (rHuG-CSF) for stem cell collection demonstrates improved neutrophil recovery after autologous bone marrow transplantationA M Stoppa, D Blaise, P Viens, et al.
Bulletin Du Cancer|January 1, 1987
[High-doses chemotherapy followed by bone marrow autograft in the treatment of small cell bronchial cancer]J L Pico, D Baume, M Ostronoff, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1985
Phase-I-II study of high-dose melphalan and autologous marrow transplantation in adult patients with poor-risk non-Hodgkin's lymphomasB Mascret, D Maraninchi, J A Gastaut, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|November 1, 1994
High-dose interleukin-2 two days a week for metastatic renal cell carcinoma: a FNCLCC multicenter studyB Escudier, A Ravaud, M Fabbro, et al.
Bone Marrow Transplantation|August 1, 1992
Intensive immunotherapy with recombinant IL2 after autologous bone marrow transplantation is associated with a high incidence of bacterial infectionsD Blaise, A M Stoppa, P Viens, et al.
Bulletin Du Cancer|January 1, 1988
[Comparison between single-dose and hyperfractionated total-body irradiation for the conditioning of allogenic grafts of the bone marrow. A retrospective study of 54 patients with malignant hematologic diseases]D Baume, J M Cosset, J L Pico, et al.
Presse Medicale (Paris, France : 1983)|October 26, 1988
[Antibiotic therapy protocol using ceftazidime 3g/day alone or in combination with vancomycin or amikacin. In febrile episodes in neutropenic patients]J P Marie, J L Pico, D Chiche, et al.
Bulletin Du Cancer|January 1, 1990
[Value of high-dose chemotherapy followed by bone marrow autograft in non-seminomatous germinal tumor with poor prognosis. Results of the combination of cisplatinum, etoposide and cyclophosphamide (PEC protocol)]D Baume, J L Pico, J P Droz, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Long-term survivors after salvage high dose chemotherapy with bone marrow rescue in refractory germ cell cancerJ P Droz, J L Pico, M Ghosn, et al.
Pageof 6

Showing results (31-40 of 52) with videos related to

Sort By:
Pageof 6
British Journal of Haematology|January 1, 1993
In vivo administration of recombinant granulocyte colony stimulating factor corrects acquired neutrophil function deficiency association with chronic graft-versus-host diseaseA M Stoppa, C Fossat, D Sainty, et al.
Bone Marrow Transplantation|May 1, 1994
Phase I study of in vivo lenograstim (rHuG-CSF) for stem cell collection demonstrates improved neutrophil recovery after autologous bone marrow transplantationA M Stoppa, D Blaise, P Viens, et al.
Bulletin Du Cancer|January 1, 1987
[High-doses chemotherapy followed by bone marrow autograft in the treatment of small cell bronchial cancer]J L Pico, D Baume, M Ostronoff, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1985
Phase-I-II study of high-dose melphalan and autologous marrow transplantation in adult patients with poor-risk non-Hodgkin's lymphomasB Mascret, D Maraninchi, J A Gastaut, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|November 1, 1994
High-dose interleukin-2 two days a week for metastatic renal cell carcinoma: a FNCLCC multicenter studyB Escudier, A Ravaud, M Fabbro, et al.
Bone Marrow Transplantation|August 1, 1992
Intensive immunotherapy with recombinant IL2 after autologous bone marrow transplantation is associated with a high incidence of bacterial infectionsD Blaise, A M Stoppa, P Viens, et al.
Bulletin Du Cancer|January 1, 1988
[Comparison between single-dose and hyperfractionated total-body irradiation for the conditioning of allogenic grafts of the bone marrow. A retrospective study of 54 patients with malignant hematologic diseases]D Baume, J M Cosset, J L Pico, et al.
Presse Medicale (Paris, France : 1983)|October 26, 1988
[Antibiotic therapy protocol using ceftazidime 3g/day alone or in combination with vancomycin or amikacin. In febrile episodes in neutropenic patients]J P Marie, J L Pico, D Chiche, et al.
Bulletin Du Cancer|January 1, 1990
[Value of high-dose chemotherapy followed by bone marrow autograft in non-seminomatous germinal tumor with poor prognosis. Results of the combination of cisplatinum, etoposide and cyclophosphamide (PEC protocol)]D Baume, J L Pico, J P Droz, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Long-term survivors after salvage high dose chemotherapy with bone marrow rescue in refractory germ cell cancerJ P Droz, J L Pico, M Ghosn, et al.
Pageof 6